Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Total 13F shares
-
19,690,657
-
Share change
-
+550,881
-
Total reported value
-
$720,748,309
-
Price per share
-
$36.60
-
Number of holders
-
70
-
Value change
-
+$20,813,593
-
Number of buys
-
47
-
Number of sells
-
16
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q4 2014
As of 31 Dec 2014,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,690,657 shares.
The largest 10 holders included
Third Rock Ventures, LLC, FMR LLC, BlackRock Fund Advisors, ORBIMED ADVISORS LLC, RS INVESTMENT MANAGEMENT CO LLC, DEERFIELD MANAGEMENT CO, ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, FEDERATED INVESTORS INC /PA/, and FRANKLIN RESOURCES INC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.